首页 | 本学科首页   官方微博 | 高级检索  
     


Personalizing Glucose-Lowering Therapy in Patients with Type 2 Diabetes and Cardiovascular Disease
Affiliation:Yale Endocrinology, Fitkin 106, Box 208020, New Haven, CT 06520-8020, USA;Center of Diabetes and Metabolism, Emory University, Diabetes and Metabolism Section, Grady Health System, Atlanta, GA, USA;Division of Endocrinology, Metabolism and Lipids, Emory University School of Medicine, 69 Jesse Hill Jr Drive, Glenn Building, Suite 202, Atlanta, GA 30303, USA;Department of Radiology, UMass Memorial Medical Center, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA;Department of Oncology and Metabolism, The Medical School, University of Sheffield, Beech Hill Road, Sheffield S10 2RX, UK;Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Michigan Medicine, 1500 East Medical Center Drive, L4000 University Hospital South, Ann Arbor, MI 48109, USA;Division of Endocrinology, Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, S. Orsola-Malpighi Hospital, Via Massarenti 9, Bologna 40138, Italy;Internal Medicine, Department of Clinical and Biological Sciences, San Luigi Gonzaga Hospital, Regione Gonzole 10, Orbassano 10043, Italy
Abstract:
Keywords:Glucose-lowering therapy  Type 2 diabetes  Cardiovascular disease
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号